A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Abstract

Long-term treatment with tetrodotoxin is associated with acceptable toxicity and, in a substantial minority of patients, resulted in a sustained analgesic effect. Further study of tetrodotoxin for moderate-to-severe cancer pain is warranted.